We’re incredibly excited to have been part of YON E Health’s journey in securing funding – all within record speed, closing the deal in just two months, from scratch.

This wouldn’t have been possible without Roswitha Verwer’s, the founder’s, unstoppable drive. She built strong value propositions for her vision with a sense of urgency that were both pivotal in getting the deal across the finish line.

This is exactly why we do this work. At UniPrisma Venture Studio, we align a founder’s drive for change with a VC’s conviction—this time with Roswitha Verwer and Dr. Peter M. Kovacs.

Explore YON E Health’s announcement, directly from them: 

𝐘𝐎𝐍 𝐄 𝐇𝐞𝐚𝐥𝐭𝐡 𝐫𝐚𝐢𝐬𝐞𝐬 €𝟐𝟓𝟎,𝟎𝟎𝟎 𝐏𝐫𝐞-𝐒𝐞𝐞𝐝 𝐈𝐧𝐯𝐞𝐬𝐭𝐦𝐞𝐧𝐭 to Build What the Healthcare System Forgot⁣: Vaginal Health That’s Data-Driven and Finally Taken Seriously⁣
⁣
When we first spoke about vaginal health and fertility, we were met with silence.
𝐁𝐮𝐭 𝐬𝐢𝐥𝐞𝐧𝐜𝐞 𝐝𝐨𝐞𝐬𝐧’𝐭 𝐜𝐫𝐞𝐚𝐭𝐞 𝐜𝐡𝐚𝐧𝐠𝐞. 𝐃𝐚𝐭𝐚 𝐝𝐨𝐞𝐬. ⁣
⁣
𝐖𝐞’𝐯𝐞 𝐨𝐟𝐟𝐢𝐜𝐢𝐚𝐥𝐥𝐲 𝐜𝐥𝐨𝐬𝐞𝐝 𝐨𝐮𝐫 𝐟𝐢𝐫𝐬𝐭 €𝟐𝟓𝟎,𝟎𝟎𝟎 𝐥𝐞𝐝 𝐛𝐲 PMK-Group, a strategic accelerator at the intersection of biotech, medtech, and clinical impact. PMK focuses on disruptive innovations that address serious unmet medical needs, improve patient outcomes, and advance the global health ecosystem⁣
⁣
𝐓𝐡𝐢𝐬 𝐢𝐬 𝐚 𝐬𝐢𝐠𝐧𝐚𝐥: 𝐭𝐡𝐞 𝐯𝐚𝐠𝐢𝐧𝐚𝐥 𝐡𝐞𝐚𝐥𝐭𝐡 𝐫𝐞𝐯𝐨𝐥𝐮𝐭𝐢𝐨𝐧 𝐢𝐬 𝐢𝐧𝐯𝐞𝐬𝐭𝐚𝐛𝐥𝐞, 𝐬𝐜𝐚𝐥𝐚𝐛𝐥𝐞, 𝐚𝐧𝐝 𝐥𝐨𝐧𝐠 𝐨𝐯𝐞𝐫𝐝𝐮𝐞.⁣
⁣
⁣𝐖𝐡𝐲 𝐢𝐭 𝐦𝐚𝐭𝐭𝐞𝐫𝐬

At YON E Health, we are creating a device for vaginal pH and temperature monitoring, empowering women with accurate fertility, cycle, and health insights.

𝐍𝐨 𝐬𝐭𝐢𝐠𝐦𝐚. 𝐍𝐨 𝐠𝐮𝐞𝐬𝐬𝐰𝐨𝐫𝐤. 𝐍𝐨 𝐰𝐚𝐢𝐭𝐢𝐧𝐠 𝐮𝐧𝐭𝐢𝐥 𝐭𝐡𝐢𝐧𝐠𝐬 𝐠𝐨 𝐰𝐫𝐨𝐧𝐠.⁣

Because vaginal health is foundational. And too many women are still left in the dark.⁣
⁣
𝐖𝐡𝐲 𝐏𝐌𝐊 𝐆𝐫𝐨𝐮𝐩 𝐢𝐧𝐯𝐞𝐬𝐭𝐞𝐝
⁣

PMK funds innovation, and they accelerate it.
From Europe to Asia, Dr. Peter M. Kovacs, founder of PMK, who is committed to women’s health with a PhD in gynecological disorders, has built one of the first private research networks in Eastern Europe, scaling clinical excellence in systems that once resisted it. ⁣
⁣
They bring deep operational and scientific expertise to de-risk and accelerate development, while also partnering with founders and innovators by providing capital, clinical insight, and regulatory guidance. Peter believes in bold founders, underserved markets, and science that dares to care.
⁣
𝐓𝐡𝐞 𝐜𝐨𝐧𝐧𝐞𝐜𝐭𝐨𝐫𝐬 𝐰𝐡𝐨 𝐦𝐚𝐝𝐞 𝐢𝐭 𝐡𝐚𝐩𝐩𝐞𝐧
⁣

UniPrisma Venture Studio — Károly Szántó and Thijmen Meijer — They helped shape the term sheet, sharpening our narrative and guiding negotiations to close.
⁣
Matias Toye, founder of Oyster Shield and Dilicheck, for their outstanding support in M&A execution and fundraising readiness.
⁣
𝐓𝐨 𝐞𝐯𝐞𝐫𝐲 𝐰𝐨𝐦𝐚𝐧 𝐰𝐡𝐨 𝐡𝐚𝐬 𝐞𝐯𝐞𝐫 𝐰𝐡𝐢𝐬𝐩𝐞𝐫𝐞𝐝, “𝐈 𝐝𝐨𝐧’𝐭 𝐟𝐞𝐞𝐥 𝐡𝐞𝐚𝐫𝐝”, 𝐰𝐞 𝐡𝐞𝐚𝐫 𝐲𝐨𝐮. ⁣

We are now opening select conversations to complete the round with aligned co-investors. ⁣Let’s talk! ⁣

👉 𝐢𝐧𝐯𝐞𝐬𝐭𝐦𝐞𝐧𝐭@𝐲𝐨𝐧𝐞.𝐠𝐥𝐨𝐛𝐚𝐥
https://yone.health/⁣
⁣
𝐁𝐞𝐜𝐚𝐮𝐬𝐞 𝐟𝐞𝐦𝐭𝐞𝐜𝐡 𝐝𝐨𝐞𝐬𝐧’𝐭 𝐧𝐞𝐞𝐝 𝐭𝐨 𝐚𝐬𝐤 𝐟𝐨𝐫 𝐚 𝐬𝐞𝐚𝐭 𝐚𝐭 𝐭𝐡𝐞 𝐭𝐚𝐛𝐥𝐞 𝐚𝐧𝐲𝐦𝐨𝐫𝐞. 💜⁣

⁣We’re building the table, with data, science, and women at the head, backed by strategic partners who make revolutions scale.⁣